VH
Vyome Holdings, Inc Stock: price and insider trades · United States
US·Mcap US$12.9M
Vyome Holdings, Inc: what insiders have been doing
Only a handful of insider records exist for Vyome Holdings, Inc, the last one from 18 November 2025, too few to describe a trend. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Vyome Holdings, Inc Strong Buy (bullish), based on 3 analysts. Average price target: US$8.83.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.84
Analyst consensus
3 analystsStrong buy
US$3.50Target US$8.83(+380%)US$15.00
Income statement
RevenueUS$319.7k
Gross profitUS$218.8k68% margin
EBITDA-US$10.3M-3228% margin
Net income-US$10.3M-3209.7% margin
Valuation
PER (trailing)1.0x
P/Book2.1x
Balance sheet & cash
Market capUS$12.9M
Total debtUS$31.3k
Free Cash Flow-US$3.7M
Debt / Equity0%
Profitability & ownership
ROE-999.2%
ROA-48.8%
% insiders52.9%
% institutions2.2%
Last declaration on 18 November 2025
Declarations3 total
- 454,456 sharesCommon StockSEC:0001213900-25-112277:0
- 7 sharesCommon StockSEC:0001213900-25-090188:0
- 762 sharesCommon StockSEC:0001213900-25-086999:0
3 of 3 declarations
About Vyome Holdings, Inc
Vyome Holdings, Inc is a company listed on the XNAS market. It focuses on developing treatments for skin diseases and other medical conditions.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
